---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-047844"
form_type: "8-K"
ticker: "TELA"
cik: "0001561921"
company_name: "TELA Bio, Inc."
filed_at: "2023-04-20T23:59:59+00:00"
generated_at: "2026-06-16T22:30:39.457593+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# TELA Bio announces public offering of 4.75M shares at $9.50 per share; expects net proceeds ~$42.1M

## Summary
- Offered 4,750,000 shares at $9.50 per share; underwriters have 30-day option for 712,500 additional shares.
- Net proceeds expected ~$42.1 million after underwriting discounts and estimated expenses.
- Use proceeds for general corporate purposes including sales, marketing, R&D, working capital, and capex.
- Offering expected to close April 21, 2023, subject to customary conditions.
- Underwriting agreement with Jefferies, Piper Sandler, and Lake Street Capital Markets.

## SEC filing metadata
- accession: 0001104659-23-047844
- form_type: 8-K
- ticker: TELA
- cik: 0001561921
- company_name: TELA Bio, Inc.
- filed_at: 2023-04-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1561921/000110465923047844/0001104659-23-047844-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1561921/000110465923047844/tm232660d3_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-047844
- JSON: https://secwatch.observer/filing/0001104659-23-047844.json
- Plain text: https://secwatch.observer/filing/0001104659-23-047844.txt

## Key facts
- Material Agreements
  TELA Bio, Inc. entered into Underwriting Agreement with Jefferies LLC, Piper Sandler & Co. and Lake Street Capital Markets, LLC, as representatives of the several underwriters valued at approximately $42.1 million (effective 2023-04-18).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Jefferies LLC, Piper Sandler & Co. and Lake Street Capital Markets, LLC, as representatives of the several underwriters
  - Value: approximately $42.1 million
  - Effective: 2023-04-18
  source text: On April 18, 2023, TELA Bio, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Jefferies LLC, Piper Sandler & Co. and Lake Street Capital Markets, LLC, as representatives of the several underwriters listed in Schedule A thereto (the “ Underwriters ”) pursuant to which the Company agreed to issue and sell 4,750,000 shares of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), to the Underwriters (the “ Offering ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1561921/000110465923047844/0001104659-23-047844-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.